Literature DB >> 29089794

Coming of age in Canada: a study of population-based genetic testing for breast and ovarian cancer.

M R Akbari1,2, N Gojska1, S A Narod1,2.   

Abstract

Entities:  

Year:  2017        PMID: 29089794      PMCID: PMC5659148          DOI: 10.3747/co.24.3828

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  17 in total

1.  Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; William D Foulkes; Nadine Tung; Charmaine Kim-Sing; Olufunmilayo I Olopade; Andrea Eisen; Barry Rosen; Carrie Snyder; Shelley Gershman; Ping Sun; Steven A Narod
Journal:  JAMA Oncol       Date:  2015-06       Impact factor: 31.777

2.  Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.

Authors:  Spring Holter; Ayelet Borgida; Anna Dodd; Robert Grant; Kara Semotiuk; David Hedley; Neesha Dhani; Steven Narod; Mohammad Akbari; Malcolm Moore; Steven Gallinger
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

3.  The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.

Authors:  Mark M Pomerantz; Sandor Spisák; Li Jia; Angel M Cronin; Istvan Csabai; Elisa Ledet; A Oliver Sartor; Irene Rainville; Edward P O'Connor; Zachary T Herbert; Zoltan Szállási; William K Oh; Philip W Kantoff; Judy E Garber; Deborah Schrag; Adam S Kibel; Matthew L Freedman
Journal:  Cancer       Date:  2017-06-13       Impact factor: 6.860

Review 4.  BRCA mutations in the management of breast cancer: the state of the art.

Authors:  Steven A Narod
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

Review 5.  Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.

Authors:  Jordan Lerner-Ellis; Sam Khalouei; Victoria Sopik; Steven A Narod
Journal:  Expert Rev Anticancer Ther       Date:  2015-11-02       Impact factor: 4.512

6.  Identification of germline genetic mutations in patients with pancreatic cancer.

Authors:  Erin E Salo-Mullen; Eileen M O'Reilly; David P Kelsen; Asad M Ashraf; Maeve A Lowery; Kenneth H Yu; Diane L Reidy; Andrew S Epstein; Anne Lincoln; Amethyst Saldia; Lauren M Jacobs; Rohini Rau-Murthy; Liying Zhang; Robert C Kurtz; Leonard Saltz; Kenneth Offit; Mark E Robson; Zsofia K Stadler
Journal:  Cancer       Date:  2015-10-06       Impact factor: 6.860

7.  Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.

Authors:  Koji Shindo; Jun Yu; Masaya Suenaga; Shahriar Fesharakizadeh; Christy Cho; Anne Macgregor-Das; Abdulrehman Siddiqui; P Dane Witmer; Koji Tamura; Tae Jun Song; Jose Alejandro Navarro Almario; Aaron Brant; Michael Borges; Madeline Ford; Thomas Barkley; Jin He; Matthew J Weiss; Christopher L Wolfgang; Nicholas J Roberts; Ralph H Hruban; Alison P Klein; Michael Goggins
Journal:  J Clin Oncol       Date:  2017-08-02       Impact factor: 44.544

8.  Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.

Authors:  Karoline B Kuchenbaecker; John L Hopper; Daniel R Barnes; Kelly-Anne Phillips; Thea M Mooij; Marie-José Roos-Blom; Sarah Jervis; Flora E van Leeuwen; Roger L Milne; Nadine Andrieu; David E Goldgar; Mary Beth Terry; Matti A Rookus; Douglas F Easton; Antonis C Antoniou; Lesley McGuffog; D Gareth Evans; Daniel Barrowdale; Debra Frost; Julian Adlard; Kai-Ren Ong; Louise Izatt; Marc Tischkowitz; Ros Eeles; Rosemarie Davidson; Shirley Hodgson; Steve Ellis; Catherine Nogues; Christine Lasset; Dominique Stoppa-Lyonnet; Jean-Pierre Fricker; Laurence Faivre; Pascaline Berthet; Maartje J Hooning; Lizet E van der Kolk; Carolien M Kets; Muriel A Adank; Esther M John; Wendy K Chung; Irene L Andrulis; Melissa Southey; Mary B Daly; Saundra S Buys; Ana Osorio; Christoph Engel; Karin Kast; Rita K Schmutzler; Trinidad Caldes; Anna Jakubowska; Jacques Simard; Michael L Friedlander; Sue-Anne McLachlan; Eva Machackova; Lenka Foretova; Yen Y Tan; Christian F Singer; Edith Olah; Anne-Marie Gerdes; Brita Arver; Håkan Olsson
Journal:  JAMA       Date:  2017-06-20       Impact factor: 56.272

9.  Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

Authors:  Colin C Pritchard; Joaquin Mateo; Michael F Walsh; Navonil De Sarkar; Wassim Abida; Himisha Beltran; Andrea Garofalo; Roman Gulati; Suzanne Carreira; Rosalind Eeles; Olivier Elemento; Mark A Rubin; Dan Robinson; Robert Lonigro; Maha Hussain; Arul Chinnaiyan; Jake Vinson; Julie Filipenko; Levi Garraway; Mary-Ellen Taplin; Saud AlDubayan; G Celine Han; Mallory Beightol; Colm Morrissey; Belinda Nghiem; Heather H Cheng; Bruce Montgomery; Tom Walsh; Silvia Casadei; Michael Berger; Liying Zhang; Ahmet Zehir; Joseph Vijai; Howard I Scher; Charles Sawyers; Nikolaus Schultz; Philip W Kantoff; David Solit; Mark Robson; Eliezer M Van Allen; Kenneth Offit; Johann de Bono; Peter S Nelson
Journal:  N Engl J Med       Date:  2016-07-06       Impact factor: 91.245

10.  Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.

Authors:  K Passaperuma; E Warner; P A Causer; K A Hill; S Messner; J W Wong; R A Jong; F C Wright; M J Yaffe; E A Ramsay; S Balasingham; L Verity; A Eisen; B Curpen; R Shumak; D B Plewes; S A Narod
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

View more
  7 in total

Review 1.  Personalised medicine and population health: breast and ovarian cancer.

Authors:  Steven A Narod
Journal:  Hum Genet       Date:  2018-10-17       Impact factor: 4.132

2.  Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City.

Authors:  Sarah M Lima; Meaghan Nazareth; Karen M Schmitt; Andria Reyes; Elaine Fleck; Gary K Schwartz; Mary Beth Terry; Grace C Hillyer
Journal:  J Community Genet       Date:  2022-10-13

3.  Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer.

Authors:  Michaela Bercovitch Sadinsky; Joanne Power; Enza Ambrosio; Laura Palma; Xing Zeng; William D Foulkes; Evan Weber
Journal:  Curr Oncol       Date:  2022-05-15       Impact factor: 3.109

Review 4.  Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives.

Authors:  Filomena Ficarazzi; Manuela Vecchi; Maurizio Ferrari; Marco A Pierotti
Journal:  Breast       Date:  2021-05-12       Impact factor: 4.380

5.  Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes.

Authors:  Lorena Incorvaia; Daniele Fanale; Giuseppe Badalamenti; Marco Bono; Valentina Calò; Daniela Cancelliere; Marta Castiglia; Alessia Fiorino; Alessia Pivetti; Nadia Barraco; Sofia Cutaia; Antonio Russo; Viviana Bazan
Journal:  Cancers (Basel)       Date:  2020-05-05       Impact factor: 6.639

6.  Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!

Authors:  Hikmat Abdel-Razeq
Journal:  Oncol Rev       Date:  2021-06-24

7.  Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.

Authors:  Daniele Fanale; Alessia Fiorino; Lorena Incorvaia; Alessandra Dimino; Clarissa Filorizzo; Marco Bono; Daniela Cancelliere; Valentina Calò; Chiara Brando; Lidia Rita Corsini; Roberta Sciacchitano; Luigi Magrin; Alessia Pivetti; Erika Pedone; Giorgio Madonia; Alessandra Cucinella; Giuseppe Badalamenti; Antonio Russo; Viviana Bazan
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.